Published in Cancer Weekly, November 13th, 2007
"Recovery of a, receptor density to steady state after HP-induced inactivation required more than 30 days. HP-metabolite 11 (reduced HP, 4-(4-chlorophenyl)-alpha-(4-fluorophenyl)-4-hydroxy-1 -piperidinebutanol), but not HP-metabolite I...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.